Abacavir/lamivudine

Details

Files

Generic Name:

Abacavir/lamivudine

Project Status:

Complete

Therapeutic Area:

HIV infection

Manufacturer:

GlaxoSmithKline

Brand Name:

Kivexa

Project Line:

Reimbursement Review

Project Number:

SR0038-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

HIV infection

Recommendation Type:

List in a similar manner to other drugs in class

Final Recommendation:

December 7, 2005

Recommendation:

List in a similar manner to other drugs in class

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : July 26, 2005